Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 4
1983 1
1984 1
1986 1
1989 2
1990 1
1991 1
1992 1
1994 1
1995 2
1996 1
1997 2
1998 4
2000 1
2002 3
2003 4
2004 1
2005 1
2006 4
2007 2
2008 3
2009 1
2010 3
2011 4
2012 3
2013 5
2014 2
2015 3
2016 4
2017 7
2018 6
2019 7
2020 5
2021 7
2022 10
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %
The following terms were not found in PubMed: 22Buell
Page 1
Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC, Ifrah N, Dombret H. Huguet F, et al. J Clin Oncol. 2009 Feb 20;27(6):911-8. doi: 10.1200/JCO.2008.18.6916. Epub 2009 Jan 5. J Clin Oncol. 2009. PMID: 19124805 Clinical Trial.

In older versus younger patients, there was a higher cumulative incidence of chemotherapy-related deaths (23% v 5%, respectively; P < .001) and deaths in first CR (22% v 5%, respectively; P < .001), whereas the incidence of relapse remained stable (30% v 32%,

In older versus younger patients, there was a higher cumulative incidence of chemotherapy-related deaths (23% v 5%, respectively; P < .00

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.
van Imhoff GW, McMillan A, Matasar MJ, Radford J, Ardeshna KM, Kuliczkowski K, Kim W, Hong X, Goerloev JS, Davies A, Barrigón MDC, Ogura M, Leppä S, Fennessy M, Liao Q, van der Holt B, Lisby S, Hagenbeek A. van Imhoff GW, et al. J Clin Oncol. 2017 Feb 10;35(5):544-551. doi: 10.1200/JCO.2016.69.0198. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029326 Clinical Trial.

Median age was 57 years (range, 18 to 83 years); 17% were age 65 years; 63% had stage III and IV disease; 71% did not achieve complete response (CR) or experience response for < 1 year on first-line R-CHOP. Response rate for O-DHAP was 38% (CR, 15%) versus 42% (CR, 2

Median age was 57 years (range, 18 to 83 years); 17% were age 65 years; 63% had stage III and IV disease; 71% did not achieve complete respo …
Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma.
Weishaar KM, Wright ZM, Rosenberg MP, Post GS, McDaniel JA, Clifford CA, Phillips BS, Bergman PJ, Randall EK, Avery AC, Thamm DH, Christman Hull AA, Gust CM, Donoghue AR. Weishaar KM, et al. J Vet Intern Med. 2022 Jan;36(1):215-226. doi: 10.1111/jvim.16341. Epub 2021 Dec 24. J Vet Intern Med. 2022. PMID: 34952995 Free PMC article.
The BORR for RAB-treated dogs was 73.2% (50.9% complete response [CR], 22.3% partial response [PR]) and 5.6% (0% CR, 5.6% PR) for placebo-treated dogs (P < .0001). ...
The BORR for RAB-treated dogs was 73.2% (50.9% complete response [CR], 22.3% partial response [PR]) and 5.6% (0% CR, 5.6% PR) …
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study.
Ghione P, Palomba ML, Ghesquieres H, Bobillo S, Patel AR, Nahas M, Kanters S, Deighton K, Hatswell A, Ma L, Limbrick-Oldfield EH, Snider JT, Wade SW, Riberio MT, Radford J, Beygi S, Gribben J. Ghione P, et al. Haematologica. 2023 Mar 1;108(3):822-832. doi: 10.3324/haematol.2022.281421. Haematologica. 2023. PMID: 36263843 Free PMC article.
ORR at 3rd LoT was 68% (CR 44%), but decreased after each LoT to 37% (CR 22%) in 5 LoT. Median OS and PFS at 3rd LoT were 68 and 11 months, respectively, and reduced to 43 and 4 months at 5 LoT. ...
ORR at 3rd LoT was 68% (CR 44%), but decreased after each LoT to 37% (CR 22%) in 5 LoT. Median OS and PFS at 3rd LoT were 68 a …
Influence of Weightbearing Computed Tomography in the Progressive Collapsing Foot Deformity Classification System.
Barbachan Mansur NS, Lalevée M, Lee HY, Ehret A, Fayed A, Mann TS, de Carvalho KAM, de Cesar Netto C. Barbachan Mansur NS, et al. Foot Ankle Int. 2023 Feb;44(2):125-129. doi: 10.1177/10711007221141898. Epub 2023 Jan 13. Foot Ankle Int. 2023. PMID: 36639923

Class A was presented in 83.9% (CR: 89.5%, P = .55), class B in 89.9% (CR: 76.4%, P < .001), class C in 93.6% (CR: 86.2%, P = .004), class D in 46.4% (CR: 34.8%, P = .006), and class E in 27.7% (CR: 22.5%, P = .158) of the classifications performed by WBCT. CONCL

Class A was presented in 83.9% (CR: 89.5%, P = .55), class B in 89.9% (CR: 76.4%, P < .001), class C in 93.6% (CR: 86.2%, P = .004), clas

The Safety and Efficacy of Intra-Arterial versus Intravenous Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer: A Meta-Analysis.
Liu C, Cui R, Li M, Feng Y, Bai H, Zhang Z. Liu C, et al. Evid Based Complement Alternat Med. 2020 Feb 25;2020:5023405. doi: 10.1155/2020/5023405. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32184892 Free PMC article. Review.
The grade 3/4 toxicity rate was 27.2%. In the intra-arterial group, the response rate was 83.1% (CR, 22.0%; partial response (PR), 61.0%), which was significantly higher than 58.5% (CR, 11.3%; PR, 47.2%) in the intravenous group (P=0.01). ...
The grade 3/4 toxicity rate was 27.2%. In the intra-arterial group, the response rate was 83.1% (CR, 22.0%; partial response ( …
On the potential of pristine Cocos nucifera L. tissues for green desalination.
Adelodun AA. Adelodun AA. Philos Trans A Math Phys Eng Sci. 2022 Apr 18;380(2221):20210145. doi: 10.1098/rsta.2021.0145. Epub 2022 Feb 28. Philos Trans A Math Phys Eng Sci. 2022. PMID: 35220769
The salinity retention ability (desalination : desorption) follows the trend: F_CR (22.2) > F_CB (19.0) D_CR (12.3) > D_CB (11.0) > D_CL (6.14) F_CL (6.10) > F_CH (4.3) > D_CH (2.1). ...
The salinity retention ability (desalination : desorption) follows the trend: F_CR (22.2) > F_CB (19.0) D_CR (12.3) > D_ …
Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis.
Lucchini G, Marsh R, Gilmour K, Worth A, Nademi Z, Rao A, Booth C, Amrolia P, Silva J, Chiesa R, Wynn R, Lehmberg K, Astigarraga I, Güngör T, Stary J, Moshous D, Ifversen M, Zinn D, Jordan M, Kumar A, Yasumi T, Veys P, Rao K. Lucchini G, et al. Blood. 2018 Nov 8;132(19):2088-2096. doi: 10.1182/blood-2018-01-827485. Epub 2018 Aug 13. Blood. 2018. PMID: 30104219 Free article.
Ten of 32 ACs activated HLH while being observed, and all underwent HSCT: 6/10 are alive and in complete remission (CR). 22/32 ACs remained asymptomatic, and 6/22 have received no treatment and are in CR at a median follow-up of 39 months. ...
Ten of 32 ACs activated HLH while being observed, and all underwent HSCT: 6/10 are alive and in complete remission (CR). 22/32 …
Rituximab exposure-response in triweekly R-CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes.
Liu S, Wang Z, Chen R, Huang H, Wang X, Peng C, Guan Y, Fang X, Guan S, Huang H, Liu T, Lin T, Huang M. Liu S, et al. Clin Transl Sci. 2022 Mar;15(3):680-690. doi: 10.1111/cts.13186. Epub 2021 Nov 29. Clin Transl Sci. 2022. PMID: 34729920 Free PMC article.
The trough concentration in the first cycle (C(1-trough) ) was significantly higher in patients achieving complete response (CR) compared with patients that did not achieve CR (22.00 mug/ml vs. 16.62 mug/ml, p = 0.0016), however, this difference between the two grou …
The trough concentration in the first cycle (C(1-trough) ) was significantly higher in patients achieving complete response (CR) compared wi …
Urinary early kidney injury molecules in children with beta-thalassemia major.
Şen V, Ece A, Uluca Ü, Söker M, Güneş A, Kaplan İ, Tan İ, Yel S, Mete N, Sahin C. Şen V, et al. Ren Fail. 2015 May;37(4):607-13. doi: 10.3109/0886022X.2015.1007871. Epub 2015 Feb 6. Ren Fail. 2015. PMID: 25656833
Significantly increased U(NAG/Cr) (0.48 0.58 vs. 0.23 0.16, p = 0.026) and U(NGAL/Cr) (22.1 18.5 vs. 11.5 6.17, p = 0.01) ratios were found in beta-TM patients compared with healthy controls. ...
Significantly increased U(NAG/Cr) (0.48 0.58 vs. 0.23 0.16, p = 0.026) and U(NGAL/Cr) (22.1 18.5 vs. 11.5 6.17, p = 0.01) rati …
105 results